ArticleMolecular genetics and genomics : MGG2025
A reference genome for Plinia edulis: expanding the pharmacological and nutraceutical potential of a neglected brazilian tree species.
Article in Molecular genetics and genomics : MGG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Widely distributed in tropical and subtropical regions, the Myrtaceae family includes several species with vast nutraceutical potential due to their rich composition of bioactive compounds with pharmacological and nutraceutical importance. Plinia edulis is a neglected and endangered Myrtaceae species of the Brazilian Atlantic Forest, with tasteful nutraceutical fruits and potential use in the pharmacological industry. Here we report the sequencing, assembling, and annotation of a reference genome for this species, towards stimulating its conservation, cultivation, domestication, and genetic improvement. The reference genome presented 98.5% BUSCO completeness, N50 = 21.2 Mb, and 37.428 gene models predicted. These gene models are related to 327 pathways of secondary metabolites biosynthesis, including 59 of terpenoids and polyketides and 40 of propanoids and flavonoids metabolism. The KEGG mapping revealed key genes for producing 20 important secondary metabolites with pharmacological significance, enlarging the opportunities for nutraceutical and pharmacological uses of the species. The prospection of SSR markers allowed primer design for 30,897 loci, of which about 75% are potentially informative for SSR and SSRseq analysis. This reference genome will assist conservation and genetic breeding programs, and the annotation will support studies on secondary metabolite production. Genetic conservation and breeding projects for P. edulis may also consider the revealed genomic potential of this species to react to environmental stresses.
Indexed as
Identifiers
40583094What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.